News

Zenflow, Inc. released three-year data from its ZEST pilot studies, demonstrating sustained positive outcomes for patients using the Zenflow...

Janssen-Cilag International NV announced promising interim results from the Phase 2b SunRISe-1 study (Cohort 4) of TAR-200, a gemcitabine-releasing...

Protara Therapeutics announced updated Phase 2 trial results for TARA-002, a cell-based therapy for Non-Muscle Invasive Bladder Cancer (NMIBC)....

Stablepharma Ltd. has initiated a Phase 1 clinical trial for its lead candidate, SPVX02, a fridge-free tetanus and diphtheria...

Foghorn Therapeutics announced preclinical data for several potential first-in-class cancer medicines, including FHD-909, a SMARCA2 inhibitor, and its selective...

Tenaya Therapeutics announced interim data from its RIDGE natural history study of adults with arrhythmogenic right ventricular cardiomyopathy (ARVC)...

Verana Health launched Qdata® Cataracts, a comprehensive dataset on cataract surgery outcomes derived from over 9 million de-identified patients...

Inmagene Biopharmaceuticals announced positive topline results from a Phase 2a trial of IMG-007, a non-depleting anti-OX40 monoclonal antibody, in...

Northstrive Biosciences, a subsidiary of PMGC Holdings, received positive feedback from the FDA regarding its pre-IND meeting request for...

SpyGlass Pharma announced positive 18-month data from its first-in-human study of a novel drug delivery platform for glaucoma and...